Additionally, the overexpression of TREM2 abrogates AD pathology via the upregulation of genes involved in phagocytosis, immune regulation and neuroprotection, culminating in reduced plaque burden and diminished neuritic dystrophy in the 5xFAD mouse model [181]. Here, TREM2 is linked to Alzheimer disease.